Liquid Embolic Agent Market Size Worth USD 613.05 Million by 2034 | CAGR: 9.7%

The liquid embolic agents market size is expected to reach USD 613.05 million by 2034, according to a new study by Polaris Market Research. The report “Liquid Embolic Agent Market Share, Size, Trends, Industry Analysis Report: By Product Type ((Ethylene Vinyl Alcohol Copolymer (EVOH), Cyanoacrylates, Others), By Application, By End User, and By Region; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Liquid embolic agents are minimally invasive solutions used for the treatment of cerebral arteriovenous malformations, aneurysms, and other vascular abnormalities. These agents include ethylene vinyl alcohol (EVOH) copolymers, cyanoacrylate adhesives, and other specialized embolic materials.

Questions? Request a sample or make an inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/liquid-embolic-agent-market/request-for-sample

Market growth is driven by the rising prevalence of neurovascular diseases, an expanding base of interventional neuroradiologists, and clinical advantages of liquid embolic agents over conventional treatments. Moreover, supportive reimbursement policies, regulatory clearances, and technological innovations in neurovascular intervention devices are reshaping the neurointerventional treatment landscape.

Liquid Embolic Agent Market Report Highlights

• Based on product type, the ethylene vinyl alcohol (EVOH) segment dominated the market in 2024, driven by its favorable safety profile, controlled polymerization process, and widespread use in neurovascular embolization.
• In terms of application, the arteriovenous malformations (AVMs) segment dominated the market in 2024, fueled by rising adoption of minimally invasive embolization procedures and supportive clinical evidence.
• Based on end user, the hospitals accounted for the largest market share in 2024, supported by advanced neurointerventional facilities, availability of skilled specialists, and favorable insurance coverage.
• North America dominated the liquid embolic agents market in 2024, fueled by strong regulatory approvals, advanced healthcare infrastructure and a large base of neurovascular disease patients.
• Asia Pacific is projected to record the fastest CAGR during the forecast period, driven by increasing awareness, growing healthcare investments, and adoption of advanced embolization procedures across China, India, and Japan.
• Key players in the global market include Medtronic plc, Johnson & Johnson, Stryker Corporation, Terumo Corporation, Balt Group, Boston Scientific Corporation, Penumbra Inc., Merit Medical Systems Inc., Guerbet Group S.A., Arsenal Medical Inc., Meril Life Sciences Pvt. Ltd., and Chemence Medical Inc.

Polaris Market Research has segmented the market report based on product type, application, end user, and region:

By Product Type Outlook (Revenue, USD Million, 2020–2034)

• Ethylene Vinyl Alcohol Copolymer (EVOH)
• Cyanoacrylates
  • N-BCA (n-Butyl Cyanoacrylate)
  • N-HCA (n-Hexyl Cyanoacrylate)
• Other Products

By Application Outlook (Revenue, USD Million, 2020–2034)

• Arteriovenous Malformations (AVM)
• Hypervascular Tumors
• Peripheral Vasculature Hemorrhage
• Other Applications

By End User Outlook (Revenue, USD Million, 2020–2034)

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers (ASCs)
• Other End Users

By Regional Outlook (Revenue, USD Million, 2020–2034)

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America